BriaCell Therapeutics Corp. (BCTX) Accumulated Expenses (2021 - 2026)
BriaCell Therapeutics (BCTX) posted Accumulated Expenses of $1.4 million for Q2 2026, up 8.44% sequentially from $1.3 million in Q1 2026, and up 34.68% YoY from $1.1 million in Q2 2025.
BriaCell Therapeutics Corp. (BCTX) Accumulated Expenses (2021 - 2026) Analysis & Trends
BriaCell Therapeutics has reported Accumulated Expenses for 6 years, with the latest figure at $1.4 million in Q2 2026.
- Quarterly Accumulated Expenses rose 34.68% year-over-year to $1.4 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.4 million (up 34.68% YoY) and the FY2025 annual result came in at $694285.0, up 139.1% from the prior year.
- Accumulated Expenses improved to $1.4 million in Q2 2026 per BCTX's latest filing, from $1.3 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $1.4 million in Q2 2026 and troughed at $87962.0 in Q1 2023.
- A 5-year average of $618976.6 and a median of $545198.5 in 2022 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2026: Accumulated Expenses tumbled 57.15% in 2024, then surged 473.77% in 2026.
- Over 5 years, Accumulated Expenses stood at $182302.0 in 2022, then surged by 236.03% to $612590.0 in 2023, then advanced by 23.19% to $754668.0 in 2024, then jumped by 57.53% to $1.2 million in 2025, then advanced by 19.11% to $1.4 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $1.4 million, $1.3 million, and $1.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 1.42 Mn |
| Jan 31, 2026 | 1.31 Mn |
| Oct 31, 2025 | 1.19 Mn |
| Jul 31, 2025 | 694,285.00 |
| Apr 30, 2025 | 1.05 Mn |
| Jan 31, 2025 | 227,599.00 |
| Oct 31, 2024 | 754,668.00 |
| Jul 31, 2024 | 290,376.00 |
| Apr 30, 2024 | 335,357.00 |
| Jan 31, 2024 | 212,870.00 |
| Oct 31, 2023 | 612,590.00 |
| Jul 31, 2023 | 677,718.00 |
| Apr 30, 2023 | 387,842.00 |
| Jan 31, 2023 | 87,962.00 |
| Oct 31, 2022 | 182,302.00 |
| Jul 31, 2022 | 477,807.00 |
| Jul 31, 2021 | 342,679.00 |